Apocrine lesions of the breast.
Quinn CM, D'Arcy C, Wells C.
Virchows Arch. 2022 Jan;480(1):177-189. doi: 10.1007/s00428-021-03185-4. Epub 2021 Sep 18.
Cystic Hypersecretory Hyperplasia of Breast.
Singh K, Falkenberry S, Eklund B, Quddus MR.
Int J Surg Pathol. 2018 Aug;26(5):432-433. doi: 10.1177/1066896917741979. Epub 2017 Dec 3.
Cystic apocrine hyperplasia is the most common finding in MRI detected breast lesions.
Ginter PS, Winant AJ, Hoda SA.
J Clin Pathol. 2014 Feb;67(2):182-6. doi: 10.1136/jclinpath-2013-201804. Epub 2013 Oct 22.
Is cystic disease related to breast cancer?
Haagensen DE Jr.
Am J Surg Pathol. 1991 Jul;15(7):687-94. doi: 10.1097/00000478-199107000-00010.
Atypical cystic hypersecretory lesions of the breast commonly harbour TP53 alterations.
Boyraz B, Sgroi DC, Iafrate AJ, Lerwill MF.
Histopathology. 2023 Dec;83(6):989-993. doi: 10.1111/his.15056. Epub 2023 Sep 28.
Breast cancer risk associated with proliferative breast disease and atypical hyperplasia.
Dupont WD, Parl FF, Hartmann WH, Brinton LA, Winfield AC, Worrell JA, Schuyler PA, Plummer WD.
Cancer. 1993 Feb 15;71(4):1258-65. doi: 10.1002/1097-0142(19930215)71:4<1258::aid-cncr2820710415>3.0.co;2-i.
Cystic hypersecretory hyperplasia and cystic hypersecretory duct carcinoma of the breast. Pathology, therapy, and follow-up of 39 patients.
Guerry P, Erlandson RA, Rosen PP.
Cancer. 1988 Apr 15;61(8):1611-20. doi: 10.1002/1097-0142(19880415)61:8<1611::aid-cncr2820610819>3.0.co;2-o.
Gross cystic disease of the breast.
Greenblatt RB, Mahesh VB, Sullivan D.
Maturitas. 1987 Aug;9(2):171-81. doi: 10.1016/0378-5122(87)90065-x.
Cystic hypersecretory hyperplasia of the breast: diagnosis on fine needle aspiration cytology.
Sandhu FH, Bashir MS, Kendal DM, Jeffree J, Saad Z.
Cytopathology. 2002 Jun;13(3):175-7. doi: 10.1046/j.1365-2303.2002.00381.x.
[Usual hyperplasia, atypical hyperplasia and carcinoma-in-situ of breast: a morphologic study].
Kan X, Shen DH, Shi B, He JS.
Zhonghua Bing Li Xue Za Zhi. 2004 Aug;33(4):312-5.
